FDA
-
-
-
-
-
-
-
NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75
-
-
-
-
-
-
-
IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense
-
-
-
-
-
-
-
ImmunoPrecise Antibodies (IPA) Met New Milestones in SARS-CoV-2 PolyTope Multi-Antibody Cocktail Development Program
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

